High-intensity focussed ultrasound (HIFU) treatment in uraemic secondary hyperparathyroidism
Open Access
- 19 October 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 27 (1), 76-80
- https://doi.org/10.1093/ndt/gfr590
Abstract
The recently developed non-invasive high-intensity focussed ultrasound (HIFU) technique for the destruction of parathyroid adenomas could also be of interest for the treatment of secondary hyperparathyroidism (SHP) in patients with chronic kidney disease (CKD). We conducted a pilot study using this method. Five chronic haemodialysis patients with severe SHP underwent one to three HIFU treatments, respectively. They had at least one or two enlarged parathyroid glands, which were accessible to this technique. In Patients 1-I and 5-V, serum intact parathyroid hormone (iPTH) could be successfully reduced in the long run. In Patient 3-N, serum iPTH decreased dramatically down to the normal range but increased again subsequently. In Patients 2-E and 4-D, transient reductions in serum iPTH were also obtained but HIFU failed to correct SHP during follow-up. Serum total calcium and phosphorus decreased in four among the five patients, either transiently or permanently. Serum total alkaline phosphatases were reduced in four of five patients. Side effects included local oedema, transient impairment of vocal cord mobility and bitonal voice. HIFU treatment may be of help in controlling SHP in selected patients with CKD. Further experience is clearly needed.Keywords
This publication has 7 references indexed in Scilit:
- High-Intensity Focused Ultrasound to Treat Primary Hyperparathyroidism: A Feasibility Study in Four PatientsAmerican Journal of Roentgenology, 2010
- Treatment of Secondary Hyperparathyroidism in CKD Patients with Cinacalcet and/or Vitamin D DerivativesClinical Journal of the American Society of Nephrology, 2009
- Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS).2008
- Preventive Measures and New Pharmacological Approaches of Calcium and Phosphate DisordersPublished by S. Karger AG ,2008
- Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidismKidney International, 2005
- Percutaneous ethanol (PEIT) and calcitrol (PCIT) injection therapy are ineffective in treating severe secondary hyperparathyroidismNephrology Dialysis Transplantation, 2004
- Guidelines for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patientsNephrology Dialysis Transplantation, 2003